menopause and infertility Flashcards
menopause
- permanent cessation of menstruation
- dx retrospectively
- amenorrhea for 12 mo
what is the average age of menopause
- 51.4 years old
risk factors affecting menopause
- genetics
- ethnicity/ race
- toxins/ exposures- tobacco can cause early menopause
- hysterectomy (even of ovaries are still intact)
peri-menopause
- avg age 47
- occurs about 4 years before dx of menopause
- variable or irregular cycles
- initially increased cycle length -> cycles become shorter
- changes in lipid metabolism and bone loss start
pathophys of menopause
- decline in quality and quantity of eggs
- granulosa cells stop making estrogen in inhibin -> loss of neg feedback loop
- FSH and LH increase
- ovary cannot respond to FSH
- permanent amenorrhea once all follicles depleted
work up for pt < 40 with menopause sx
- requires full work up
work up for pts 40-45 with menopause sx
- r/o other causes of menstrual dysfunction
- likely peri-menopause
work up for pts > 45 with menopause sx
- diagnostic testing not recommended
- likely start of menopause
si/sx of menopause
- hallmark= hot flashes
- sleep disturbances
- mood changes
- cognitive changes
- vaginal dryness (may lead to UTIs)
- sexual function
- breast pain/ tenderness
- joint pain and aches
vaginal changes with menopause
- labia minora fusion or resorption
- atrophic, pale
- lack of rugae
- diminished elasticity and turgor
- may before shortened and narrower- can prevent with sex
- pelvic muscle lose tone -> possible prolapse, urge/ stress incontinence
cervical changes with menopause
- atrophic
- flush with vagina
- decrease in size
- can become stenotic
skin and hair changes with menopause
- thinning of skin with decreased elasticity
- loss of pubic and axillary hair
- hirsutism d/t increased androgens
long term effects of menopause
- dementia- limited evidence
- CV disease
- osteoporosis- accel after menopause
- rate of bone loss highest 1 year prior to FMP through 2 years after FMP
lifestyle modifications for menopause tx
- lower room temps
- dress in layers
- avoid triggers- i.e. spicy food, stress
- smoking cessation
- weight loss
- lubricants, vaginal dilators, intercourse
menopausal hormone therapy (MHT)
- indicated for women whose sx cannot be controlled with lifestyle modifications
- unopposed estrogen tx is risk for dev endometrial hyperplasia -> increased ca risk
contraindications to MHT
- breast cancer
- CAD
- VTE
- CVA, TIA
- liver disease
- unexplained vaginal bleeding
- endometrial cancer
when is PO estrogen avoided for menopause tx
- hyperTG
- gallbladder disease
- thrombophilias
- migraine HA with aura
considerations for MHT
- calculate CV and breast ca risk before starting tx
- start with lowest dose and titrate up
- consider anticonvuslants, alcohol use, ESRD etc.
- taper meds to d/c- better tolerated
how long do you use MHT for?
- no set duration
- usu used for 2-3 years
- max of 5 years or not beyond 60
estrogen formulations
- PO- if baseline VTE and TIA risk low, more favorable effect on lipids
- transdermal- lower risk VTE, TIA, hyperTG
- topical gels and lotions
- intravaginal creams and tablets
- vaginal rings
progesterone treatment
- PO micronized progesterone given as first line
- give for 12 d/mo if perimenopause
- give every day of month after menopause
- IUD may be considered as off label tx if cannot tolerate PO
SERMS for menopause tx
- used for vasomotor and osteoporosis sx
- prevents endometrial hyperplasia (progestin not needed)
- usu use bazedoxifine
- increased VTE risk
OCPs for menopause tx
- can be used in perimenopausal women who desire contraception or control of heavy leednig
- avoided in obese, smoker, HTN, migraines